Swiss pharma giant Roche agrees $7.1 billion deal to buy Telavant Holdings
[ad_1]
[ad_2]
Source link
https://worldnews2023.com/top-stories/swiss-pharma-giant-roche-agrees-7-1-billion-deal-to-buy-telavant-holdings/?feed_id=305695&_unique_id=66650006a8e9d
A photo showing the logo of Swiss pharmaceutical giant Roche in Basel.
SEBASTIEN BOZON | AFP | Getty Images
Swiss health care company Roche announced it would acquire Telavant Holdings Monday, in a deal worth $7.1 billion.
Telavant creates drugs for people suffering from inflammatory and fibrotic diseases, and is in the process of developing a "promising new therapy" for patients with Crohn's disease, Roche said in a press release.
This is a breaking news story, please check back later for more.
Comments
Post a Comment